Data is not available at this time.
Ping An Healthcare and Technology operates a comprehensive online healthcare ecosystem in China, integrating digital medical services with product commerce. Its core revenue model is multifaceted, generating income from online consultations, hospital referral fees, direct sales of pharmaceuticals and wellness products, and technology services for healthcare institutions. The company leverages its affiliation with Ping An Insurance Group to cross-sell services, creating a synergistic health management platform. Operating in the competitive Healthcare Information Services sector, it positions itself as a one-stop solution for consumers seeking convenient, integrated care. Its market position is strengthened by its vast technological infrastructure and data analytics capabilities, which personalize user experiences and improve service efficiency. This dual focus on B2C telehealth and B2B technology solutions provides diversified revenue streams and a defensible moat in China's rapidly digitizing healthcare market.
The company reported revenue of HKD 4.81 billion for the period. It achieved a net income of HKD 81.4 million, indicating a return to profitability after prior challenges. Operating cash flow was positive at HKD 99.3 million, demonstrating an ability to generate cash from its core operations, which is a key efficiency metric for a growth-oriented technology platform.
Diluted earnings per share stood at HKD 0.075, reflecting the company's current earnings power. Capital expenditures were modest at HKD 34.2 million, suggesting a capital-light business model that does not require significant ongoing investment in physical assets, thereby supporting returns on invested capital as the platform scales.
The balance sheet is characterized by a strong liquidity position, with cash and equivalents of HKD 2.04 billion significantly outweighing a minimal total debt of HKD 45.0 million. This results in a robust net cash position, providing substantial financial flexibility to fund future growth initiatives and weather potential market volatility without solvency concerns.
The company has initiated a dividend policy, distributing HKD 9.7 per share. This substantial payout, relative to its earnings, may signal a commitment to shareholder returns, though it is atypical for a growth-stage tech company and warrants monitoring for sustainability alongside its expansion objectives in the dynamic online healthcare market.
With a market capitalization of approximately HKD 45.3 billion, the market is valuing the company at a significant premium to its current revenue and earnings. A beta of 0.985 indicates stock volatility nearly in line with the broader market, reflecting investor perceptions of its risk profile balanced against its growth potential in the Chinese digital health sector.
The company's primary strategic advantage is its integration within the Ping An ecosystem, providing access to a large customer base and synergies with insurance products. The outlook hinges on its ability to monetize its platform further, expand its user engagement, and navigate the competitive and regulatory landscape of China's healthcare sector to achieve sustainable, profitable growth.
Company Annual ReportHong Kong Stock Exchange Filings
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |